Association of Low PON1 Type Q (Type A) Arylesterase Activity with Neurologic Symptom Complexes in Gulf War Veterans
- 1 June 1999
- journal article
- research article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 157 (3), 227-233
- https://doi.org/10.1006/taap.1999.8703
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxonBritish Journal of Pharmacology, 1997
- Increased Neurotoxicity Following Concurrent Exposure to Pyridostigmine Bromide, DEET, and ChlorpyrifosFundamental and Applied Toxicology, 1996
- Paraoxonase protects against chlorpyrifos toxicity in miceToxicology Letters, 1995
- Serum paraoxonase status: A major factor in determining resistance to organophosphatesJournal of Toxicology and Environmental Health, 1993
- Delayed neurotoxic effect of sarin in mice after repeated inhalation exposureJournal of Applied Toxicology, 1993
- Interindividual Variations in Enzymes Controlling Organophosphate Toxicity in ManHuman & Experimental Toxicology, 1992
- Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in ratsToxicology and Applied Pharmacology, 1990
- The human serum paraoxonase—Polymorphism and specificityToxicological & Environmental Chemistry, 1988
- Differential Inhibition of Human Serum Cholinesterase with Fluoride: Recognition of Two New PhenotypesNature, 1961
- A METHOD FOR THE DETECTION OF ATYPICAL FORMS OF HUMAN SERUM CHOLINESTERASE. DETERMINATION OF DIBUCAINE NUMBERSCanadian Journal of Biochemistry and Physiology, 1957